Delta Global Management LP Has $2.02 Million Stock Position in CME Group Inc. $CME

Delta Global Management LP trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME) by 22.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 7,402 shares of the financial services provider’s stock after selling 2,157 shares during the period. Delta Global Management LP’s holdings in CME Group were worth $2,021,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CME. Asset Dedication LLC raised its position in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 37 shares during the period. FNY Investment Advisers LLC acquired a new position in CME Group during the fourth quarter valued at $27,000. Hilton Head Capital Partners LLC acquired a new position in CME Group during the fourth quarter valued at $28,000. Legacy Wealth Managment LLC ID raised its position in CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after buying an additional 71 shares during the period. Finally, Global Wealth Strategies & Associates raised its position in CME Group by 1,250.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock valued at $30,000 after buying an additional 100 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Trading Down 1.7%

NASDAQ:CME opened at $261.60 on Wednesday. The stock’s 50 day moving average price is $283.14 and its 200 day moving average price is $287.95. CME Group Inc. has a 52 week low of $244.56 and a 52 week high of $329.16. The company has a market capitalization of $94.79 billion, a P/E ratio of 22.32, a P/E/G ratio of 2.97 and a beta of 0.21. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the prior year, the company posted $2.80 earnings per share. The firm’s revenue was up 14.5% on a year-over-year basis. On average, research analysts forecast that CME Group Inc. will post 12.28 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a $1.30 dividend. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. CME Group’s dividend payout ratio is currently 44.37%.

Wall Street Analysts Forecast Growth

CME has been the topic of several recent analyst reports. The Goldman Sachs Group dropped their price target on CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a research report on Thursday, April 23rd. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and upped their price target for the company from $316.00 to $323.00 in a research report on Thursday, June 11th. Raymond James Financial upped their price target on CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research report on Monday, April 6th. Morgan Stanley dropped their target price on CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a research report on Thursday, April 23rd. Finally, Jefferies Financial Group dropped their target price on CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a research report on Thursday, April 9th. Eleven investment analysts have rated the stock with a Buy rating, five have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $305.71.

Insider Buying and Selling

In other news, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.